Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | EPRS1 | P07814 | 2/20 | 0.38 |
| ▸ | PTGFR | P43088 | 13/20 | 0.35 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8215300 | 0.92 | ALDH1A1 (0.39) | ALDH1A1L3MBTL1EPRS1PTGFR | |
| SCHEMBL13053997 | 0.88 | ALDH1A1 (0.39) | ALDH1A1L3MBTL1EPRS1PTGFR | |
| SCHEMBL3752012 | 0.84 | ALDH1A1 (0.43) | ALDH1A1L3MBTL1 | |
| SCHEMBL3754265 | 0.80 | ALDH1A1 (0.42) | ALDH1A1L3MBTL1 | |
| SCHEMBL830844 | 0.77 | ALDH1A1 (0.49) | ALDH1A1L3MBTL1 | |
| SCHEMBL833331 | 0.73 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1 | |
| SCHEMBL831624 | 0.73 | EPRS1 (0.48) | ALDH1A1L3MBTL1EPRS1 | |
| SCHEMBL830819 | 0.72 | ALDH1A1 (0.40) | ALDH1A1L3MBTL1 | |
| SCHEMBL8209904 | 0.72 | ALDH1A1 (0.43) | ALDH1A1L3MBTL1 | |
| SCHEMBL3757232 | 0.71 | ALDH1A1 (0.42) | ALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100298221-A1 | 2-PHENOXY NICOTINE ACID DERIVATIVE AND USE THEREOF | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2010-11-25 | — | — | US | disclosed |
| US-20100298221-A1 | 2-PHENOXY NICOTINE ACID DERIVATIVE AND USE THEREOF | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2010-11-25 | — | — | US | disclosed |
| US-20100298221-A1 | 2-PHENOXY NICOTINE ACID DERIVATIVE AND USE THEREOF | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2010-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100298221-A1 | 2-PHENOXY NICOTINE ACID DERIVATIVE AND USE THEREOF | NAPRT, PNPO, FABP3 | ALDH1A1 1855/4885L3MBTL1 2518/4885EPRS1 2973/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.